CUROGEN Technology Co., Ltd.

CUROGEN

pharmaceutical preparations for diagnosis; diagnostic agents for pharmaceutical use; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of auto-immune diseases; monoclonal antibodies for medical purposes; polyclonal antibodies for medical purposes; compounds for treating cancer; biological preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; chemical preparations for pharmaceutical purposes for the treatment of cancer or autoimmune diseases; immunoassay reagents for medical use; biological preparations for medical purposes for the treatment of cancer or autoimmune diseases; chemico-pharmaceutical preparations for the treatment of cancer or autoimmune diseases; preparations of microorganisms for medical purposes; pharmaceuticals for the treatment of cancer or autoimmune diseases; pharmaceutical compositions for the treatment of cancer or autoimmune diseases;pharmaceutical drug development services; research on the subject of pharmaceuticals; pharmaceutical drug development services; medicine research; analysis and evaluation of medical product development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information on medical research being testing, inspection, and research of medical products; evaluating of clinical trial progress; development of biologics; research of biologics; biological research and analysis; drug discovery services; conducting clinical trials for others; scientific research; clinical trials; biological laboratory services; laboratory research in the field of chemistry; laboratory analysis in the field of chemistry; research and development of new products for others; pharmaceutical research and development;